Literature DB >> 28413520

Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis.

Dong Xiao1, Lu Wang1, Daquan Zhang1, Dongming Xiang1, Qi Liu1, Xuezhong Xing2.   

Abstract

The present retrospective study aimed to investigate the prognostic factors for critically ill patients with an Acinetobacter baumannii (A. baumannii) infection. A total of 37 patients from the intensive care unit (ICU) were enrolled in the study. Data was collected from patients, including age, gender, ethnicity, A. baumannii infection status, concurrent infection status, prescribed antibiotics, Acute Physiology and Chronic Health Evaluation II (APACHE II) and sepsis-related organ failure assessment (SOFA) scores, procalcitonin level, site of infection, shock, sepsis and renal replacement therapy status. Univariate and multivariate analyses were performed to determine the prognostic factors for mortality. In total, 8 out of the 37 patients included in this trial did not survive, resulting in an ICU mortality rate of 21.6%. Univariate analysis indicated that, in comparison with the survival group, APACHE II and SOFA scores were significantly higher in the mortality group (P<0.002 and P<0.001, respectively). A larger number of patients with septic shock were detected in the mortality group in comparison with the survival group (n=4 and n=3, respectively), whereas a larger number of patients were infected with multidrug-resistant A. baumannii (MDRAB) in the survival group in comparison with the mortality group (51.9 and 14.3%, respectively). However, the prognosis was not significantly influenced by antibiotics administered, mixed infection or the site of infection. Multivariate analysis demonstrated that the APACHE II score was the only independent factor affecting the disease prognosis. Receiver operating characteristic curve analysis of the APACHE II score demonstrated that the area under the curve was 0.845±0.078. In patients with an APACHE II score of 15, the sensitivity and specificity predictions for mortality were 87.5% and 72.4%, respectively. The APACHE II score at diagnosis was the only independent factor found to assist in the prognosis of mortality for patients in the ICU with an A. baumannii infection. In conclusion, the results of the present study demonstrated that the APACHE II score may contribute towards the prognostic evaluation of patients in the ICU with an A. baumannii infection.

Entities:  

Keywords:  Acinetobacter baumannii; critically ill patients; prognosis; retrospective analysis

Year:  2017        PMID: 28413520      PMCID: PMC5377569          DOI: 10.3892/etm.2017.4137

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  16 in total

1.  An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment.

Authors:  Lisa L Maragakis; Sara E Cosgrove; Xiaoyan Song; Denny Kim; Patricia Rosenbaum; Nancy Ciesla; Arjun Srinivasan; Tracy Ross; Karen Carroll; Trish M Perl
Journal:  JAMA       Date:  2004-12-22       Impact factor: 56.272

Review 2.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  [Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections].

Authors:  Yan Shi; Ying-chun Xu; Ye Liu; Wei Du; Xi Rui; Yao Wang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2012-10-30

4.  Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study.

Authors:  J L García-Garmendia; C Ortiz-Leyba; J Garnacho-Montero; F J Jiménez-Jiménez; C Pérez-Paredes; A E Barrero-Almodóvar; M Gili-Miner
Journal:  Clin Infect Dis       Date:  2001-08-22       Impact factor: 9.079

5.  Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.

Authors:  Young Kyoung Park; Sook-In Jung; Kyong-Hwa Park; Dae Hun Kim; Ji Young Choi; Su Hwan Kim; Kwan Soo Ko
Journal:  J Med Microbiol       Date:  2011-08-18       Impact factor: 2.472

6.  Attributable mortality of nosocomial Acinetobacter bacteremia.

Authors:  Mordechai Grupper; Hanna Sprecher; Tania Mashiach; Renato Finkelstein
Journal:  Infect Control Hosp Epidemiol       Date:  2007-02-07       Impact factor: 3.254

7.  [Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].

Authors:  Feza Bacakoğlu; Pervin Korkmaz Ekren; Mehmet Sezai Taşbakan; Burcu Başarik; Hüsnü Pullukçu; Söhret Aydemir; Alev Gürgün; Ozen Kaçmaz Başoğlu
Journal:  Mikrobiyol Bul       Date:  2009-10       Impact factor: 0.622

Review 8.  Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis.

Authors:  E V Lemos; F P de la Hoz; T R Einarson; W F McGhan; E Quevedo; C Castañeda; K Kawai
Journal:  Clin Microbiol Infect       Date:  2013-10-17       Impact factor: 8.067

9.  Control of multidrug resistant bacteria in a tertiary care hospital in India.

Authors:  Namita Jaggi; Pushpa Sissodia; Lalit Sharma
Journal:  Antimicrob Resist Infect Control       Date:  2012-06-06       Impact factor: 4.887

10.  Attributable mortality of Acinetobacter baumannii: no longer a controversial issue.

Authors:  Matthew E Falagas; Petros I Rafailidis
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  4 in total

1.  A Pilot Study of Antibiotic Regimens for Infections Caused by Acinetobacter baumannii in a Secondary Hospital in Thailand.

Authors:  Ronnawich Suphansatit; Suriyon Uitrakul
Journal:  Infect Drug Resist       Date:  2020-12-17       Impact factor: 4.003

2.  Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.

Authors:  Deena Jalal; Mariam G Elzayat; Aya A Diab; Hend E El-Shqanqery; Omar Samir; Usama Bakry; Reem Hassan; Mervat Elanany; Lobna Shalaby; Ahmed A Sayed
Journal:  mSphere       Date:  2021-11-17       Impact factor: 4.389

Review 3.  Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection.

Authors:  Subhasree Roy; Goutam Chowdhury; Asish K Mukhopadhyay; Shanta Dutta; Sulagna Basu
Journal:  Front Med (Lausanne)       Date:  2022-03-24

Review 4.  Gearing up for battle: Harnessing adaptive T cell immunity against gram-negative pneumonia.

Authors:  Catherine A Gao; Luisa Morales-Nebreda; Chiagozie I Pickens
Journal:  Front Cell Infect Microbiol       Date:  2022-08-18       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.